Why some cancers respond to drugs and others don’t: IBM by Arlene Weintraub Monday, March 25, 2019 Researchers at Mount Sinai and IBM found a link between responses to some cancer treatments and mitochondria, the energy centers in cells.
IBM uses machine learning to detect Alzheimer’s in blood by Arlene Weintraub Monday, March 11, 2019 IBM researchers have identified four proteins in blood that can predict the buildup of amyloid-beta, a marker of Alzheimer's, with high accuracy.
Boehringer, IBM link up for blockchain clinical trials in Canada by Conor Hale Tuesday, February 12, 2019 The Canada-based units of Boehringer Ingelheim and IBM will work together to employ blockchain record-keeping technology in clinical trials.
Synthetic polymers could tackle resistant superbugs by Amirah Al Idrus Friday, March 9, 2018 Synthetic polymers invented by IBM, which killed five types of superbugs, could be the answer to antibiotic resistance.
Elekta strikes deal to build IBM Watson into cancer care software by Nick Paul Taylor Friday, February 2, 2018 The agreement with IBM clears Elekta to start offering the artificial intelligence technology alongside its oncology information system.
FDA puts MedyMatch image analysis software on fast track by Nick Paul Taylor Monday, January 29, 2018 The designation sets MedyMatch up to receive advice from the FDA as it goes about advancing the software toward a filing for approval.
Quantib bags cash to scale machine learning business by Nick Paul Taylor Wednesday, November 29, 2017 GE-partnered Quantib will use the cash to move products related to stroke, lung disorders, oncology and bone structures toward commercialization.
IBM, JDRF to unravel Type 1 diabetes risk factors with machine learning by Amirah Al Idrus Friday, August 18, 2017 IBM and JDRF will use machine learning to identify risk factors that cause the onset of Type 1 diabetes in children.
Instagram shows prevalence of ‘off-label’ CGM placement—News of Note by Amirah Al Idrus Wednesday, August 9, 2017 Here's Wednesday's dose of medtech news of note.
Study: Machine learning could lead to objective schizophrenia diagnosis by Amirah Al Idrus Friday, July 21, 2017 IBM and the University of Alberta developed algorithms that predict schizophrenia, which could lead to objective measures to diagnose the disorder.
